Skip to content
Mesothelioma.net
phone iconCall1-800-692-8608 chat icon Chat 24/7 Live Chat
Menu
  • Malignant Mesothelioma
    • About Mesothelioma
      • How to Survive Mesothelioma
      • 100 Questions & Answers about Mesothelioma (Free Book)
      • Symptoms
      • Diagnosis
      • Prognosis
      • Life Expectancy
    • Types
      • Pleural
      • Peritoneal
      • Epithelioid
      • Sarcomatoid
      • Biphasic
    • Stages
      • Stage 1
      • Stage 2
      • Stage 3
      • Stage 4
    • Additional Information
      • Causes
      • Asbestos and Its Dangers
      • Facts
      • Support
      • Financial Compensation
      • FREE Mesothelioma Packet
  • Treatment
    • Treatment Options
      • Surgery
      • Chemotherapy
      • Radiation Therapy
      • Multimodal Therapy
      • Medications
      • Palliative Treatment
    • Find Top Doctors
      • Doctors
      • Treatment Centers
      • Treatment & Doctors Near You
      • New Treatments
      • Care Providers
      • Clinical Trials
      • Costs
  • Asbestos Trusts
  • Compensation
  • Veteran Assistance
    • Mesothelioma and Veterans
      • VA Claims for Mesothelioma
      • Vietnam Veterans
    • Military Branches and Asbestos
      • Navy Veterans
      • Navy Ships
      • Marine Corps Veterans
      • Army Veterans
      • Air Force Veterans
      • U.S. Coast Guard
  • Surviving Mesothelioma
  • About Us / Contact
  • Home
  • ›
  • Malignant Mesothelioma
  • ›
  • Genetic Components
Page Updated: June 24, 2022

Genetic Components of Malignant Mesothelioma

Anne Courtney Page Medically Reviewed and Edited by Anne Courtney, AOCNP, DNP

FREE Mesothelioma Packet

Fact Checked

This page has been fact-checked by a Doctor of nursing practice specializing in Oncology and has experience working with mesothelioma patients.

FREE Mesothelioma Packet

Sources of information are listed at the bottom of the article. We make every attempt to keep our information accurate and up-to-date. 

Please Contact Us with any questions or comments.

The genetic components of malignant mesothelioma are not well understood. Asbestos is the most important risk factor and cause of this cancer, but individual genetics likely also play a role.

FREE Mesothelioma Packet

Can Mesothelioma Be Genetic and Hereditary?

Although genes do not necessarily cause malignant mesothelioma, genetic factors influence cancer development after carcinogen exposure. Some people seem more likely to develop mesothelioma after exposure to asbestos fibers than others. Their genes may be the reason.[1]

Are Some People Genetically Predisposed to Mesothelioma?

Mesothelioma is not caused by any specific gene. However, recent research into populations of people where mesothelioma is prevalent suggests some individuals may be genetically prone to mesothelioma and other cancers. These groups of populations may be geographic groups or groups of relatives.

What Other Genetic Factors Influence the Development of Mesothelioma?

Recent research seeks to better understand genetic factors that may influence the development of mesothelioma. Since only a fraction of people who experience long-term asbestos exposure develop mesothelioma, researchers suggest a person’s genetics may be involved in the process.

In people with mesothelioma, certain tumor-suppressing genes appear to be mutated when compared to those who have been exposed but did not develop the disease.

Tumor Suppressor Genes: An In-Depth Look

Tumor suppressing genes are bits of DNA that suppress the growth and spread of malignant tumors, including mesothelioma. Recent studies of these genes and their expression in mesothelioma patients suggest some people with mesothelioma risk factors do not develop cancer, but others in the same occupational or environmental conditions do because of mutations in tumor suppressor genes.

BAP1 Gene

BRCA-associated protein 1 (BAP1) is a tumor suppressor gene that is mutated in many malignant mesothelioma patients. Alterations to this gene prohibit the body’s ability to self-regulate and destroy precancerous cells. This mutation is often found in mesothelioma tissue. Having this mutation in the cancer tissue is associated with improved survival.

Those with germline mutations, or inherited mutations, might be seen in earlier onset mesothelioma and it also tends to be less aggressive. A Japanese study of patients with mesothelioma found the BAP1 gene is often inactivated, leading to improper modification of histones in the body.

This improper modification may facilitate the growth and spread of mesothelioma and other cancers. BAP1 is thought to be partially responsible for the prevalence of mesothelioma in certain families.[2]

NF2 Gene

Another tumor suppressor linked to mesothelioma development is neurofibromatosis type 2 (NF2). This gene, when functioning properly, regulates the proliferation of cancer cells.

When mutated, NF2 allows malignant tumors to grow and spread unchecked. Approximately 35-40% of patients with mesothelioma carry inactivating mutations.[3]

LATS2 Gene

Large tumor suppressor homolog 2 (LATS2) is another gene often mutated in mesothelioma patients. When working correctly, LATS2 inhibits cancer cell growth. LATS2 is often altered or even deleted in those with malignant mesothelioma.

This gene is also associated with the Hippo pathway, by which a fetus’ internal organs are generated. This same pathway may malfunction to create tumor cells in mesothelioma patients.[4] This has also been found to be co-occurring with a mutation in the NF2 gene.

Genetic Cause of Peritoneal Mesothelioma

Researchers at Brigham and Women’s Hospital found a genetic similarity in three women with peritoneal mesothelioma. Each patient had mutations in the ALK gene. It is a rare potential cause of the cancer but one that could lead to targeted treatments.[5]

How Does Asbestos Cause Genetic Damage?

Much of the research into the genetics of mesothelioma investigates existing mutations people have that contribute to the disease. Also important to consider is how exposure to asbestos affects DNA, leading to the development of mesothelioma.

Studies have found that asbestos fibers damage DNA in a few ways:[6]

  • Breaks double strands of DNA
  • Aberrations in chromosomes
  • Abnormal segregation of chromosomes

Researchers have determined that fibers of asbestos directly interact with chromosomes and DNA molecules to cause this damage. They also indirectly damage DNA by producing reactive oxygen compounds that in turn interact with DNA. Accumulated damage to DNA can lead to mesothelioma or other cancers.

Genetics and Mesothelioma Treatment

Understanding the role of genes in mesothelioma is important for developing more effective treatments. For example, researchers discovered that the BAP1 mutation causes people to develop resistance to chemotherapy, limiting its effectiveness.[7]

Restoring the protein associated with the gene and correcting other issues associated with the mutation makes patients more responsive to chemotherapy.

Unfortunately, other types of gene therapy used to treat mesothelioma have been limited in effectiveness. It is an ongoing area of research.

Do Genetics Affect Mesothelioma Prognosis?

Genetic mutations contribute to the development of mesothelioma and also impact the outcomes. Ironically, it seems that mutations that predispose someone to mesothelioma could also help them live longer.

Studies show that certain DNA tumor suppressor mutations, like BAP1, improve survival time in patients with mesothelioma as compared to patients without the mutation.[8]

The role of genetic testing is continually expanding as researchers learn more. Be sure to share your family history with your physician to see if you should be tested for genetic mutations. There is also current research being done on also testing the tissue itself that may be unique to the cancer. This would allow for more targeted treatments and diagnostic testing in the future.

Get Your FREE Mesothelioma Packet

Page Medically Reviewed and Edited by Anne Courtney, AOCNP, DNP

Anne Courtney

Anne Courtney has a Doctor of Nursing Practice degree and is an Advanced Oncology Certified Nurse Practitioner. She has years of oncology experience working with patients with malignant mesothelioma, as well as other types of cancer. Dr. Courtney currently works at University of Texas LIVESTRONG Cancer Institutes.

Connect with Doctor of Nursing Practice Anne Courtney
References
  1. National Organization for Rare Disorders. (n.d.). Mesothelioma.
    Retrieved from: https://rarediseases.org/rare-diseases/mesothelioma/
  2. Melaiu, O., Gemignani, F., and Landi, S. (2018, January). The Genetic Susceptibility in the Development of Malignant Pleural Mesothelioma. J. Thorac. Dis. 10(Suppl 2). S246-S252.
    Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830564/
  3. Ladanyi, M., Zauderer, M.G., Krug, L.M., Ito, T., McMillan, R., Bott, M., and Giancotti, F. (2012, September 1). New Strategies in Pleural Mesothelioma: BAP1 and NF2 as Novel Targets for Therapeutic Development and Risk Assessment. 18(17), 4485-90.
    Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432735/
  4. Mizuno, T., Murakami, H., Fujii, M., Ishiguro, F., Tanaka, I., Kondo, Y., Akatsuka, S., Toyokuni, S., Yokoi, K., Osada, H., and Sekido, Y. (2012, January 30). YAP Induces Malignant Mesothelioma Cell Proliferation by Upregulating Transcription of Cell Cycle-Promoting Genes. Oncongene. 31, 5117-22.
    Retrieved from: https://www.nature.com/articles/onc20125
  5. Science Daily. (2017, September 14). Rare Genetic Cause of Peritoneal Mesothelioma Points to Targeted Therapy.
    Retrieved from: https://www.sciencedaily.com/releases/2017/09/170914152347.htm
  6. Nymark, P., Lindholm, P.M., Korpela, M.V., Lahti, L., Ruosaari, S., Kaski, S., Hollmen, J., Anttila, S., Kinnula, V.L., and Knuutila, S. (2007). Gene Expression Profiles in Asbestos-Exposed Epithelial and Mesothelial Lung Cell Lines. BMC Genomics, 8(62), doi: 10.1186/1471-2164-8-62.
    Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1821332/
  7. Bononi, A., et al. (2017, June 14). BAP1 Regulates IP3R3-Mediated Ca2+ Flux to Mitochondiria Supressing Cell Transformation. Nature. 546, 549-53.
    Retrieved from: https://www.nature.com/articles/nature22798
  8. Hassan, R., Morrow, B., Thomas, A., and Churpek, J.E. (2019, April 11). Inherited Predisposition to Malignant Mesothelioma and Overall Survival Following Platinum Chemotherapy. PNAS. 116(18), 9008-13.
    Retrieved from: https://www.pnas.org/doi/abs/10.1073/pnas.1821510116
View All References

Site Navigation

Home
Malignant Mesothelioma
How to Survive Mesothelioma
100 Questions & Answers about Mesothelioma (Free Book)
Surviving Mesothelioma - Beating the Odds (Free Book)
FREE Mesothelioma Packet
Symptoms
Shortness of Breath
Cough
Night Sweats and Fever
Weight Loss
Pain
Difficulty Swallowing
Fatigue and Muscle Weakness
Gastrointestinal Complications
Diagnosis
Pathology
Staging
Stage 1
Stage 2
Stage 3
Stage 4
Metastasis and Progression
Brain Metastasis
Biopsy
miRview Test
Imaging
Fine Needle Aspiration Biopsy in Mesothelioma
Biomarkers and Blood Tests
Calretinin
Prognosis
Remission
Recurrence
Death Rate
Life Expectancy
Search for a Mesothelioma Cure
Types
Pleural
Peritoneal
Epithelioid
Sarcomatoid
Biphasic
Pericardial
Testicular
Cell Types
Rare Subtypes of Mesothelioma
Deciduoid
Desmoplastic
Heterologous
Lymphohistiocytoid
Well-Differentiated Papillary
Tubulopapillary
Small Cell
Benign
Adenomatoid
Cystic
Unresectable
Localized
Idiopathic
Omental
Causes
Risk Factors
Latest Research
Genetic Components
Incidence
Latency Period
Mesothelioma Tumor
Health Insurance Coverage
Related Conditions
Immunodeficiency Disorders
Cholangiocarcinoma
Atelectasis
Pleural Plaques
Pleural Thickening
Pleural Effusion
Peritoneal Effusion (Ascites)
Mesothelial Hyperplasia and Proliferation
Pleuritis and Pleurisy
COPD
Anemia
Breast Cancer
Prevention
Complications
Misdiagnosis
Mesothelioma Commercial
Talcum Baby Powder
Lawyer
Lawsuits
Class Action Lawsuits
Settlements
Simian Virus 40
Differences From Other Cancers
Lung Cancer
Women
Children and Young Adults
Unknown Asbestos Exposure
Mesothelioma Without Asbestos
Cause of Death
Facts 
History
Awareness
Government and Research
National Mesothelioma Virtual Bank
Support
What to Expect
Living with Mesothelioma
Help a Loved One
Wrong and Right Things to Say
Caregivers
Financial Tips
Faith
Nutrition and Lifestyle
Intimacy
Mesothelioma and Fertility in Men
Fertility in Women with Mesothelioma
Emotional Health
COVID-19
Assisted Living
Hospice Care
Dying from Mesothelioma
Mourning
Coping Guide for Children
End-of-Life Decisions
Mesothelioma Awareness Day
Compensation for Victims
Lawyer
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington D.C.
Washington
West Virginia
Wisconsin
Wyoming
Lawsuit
Settlements
Statute of Limitations
Treatment
Surgery
Side Effects
Pneumonectomy
Extrapleural Pneumonectomy
Lobectomy
Pleurectomy/Decortication
Post Op Care
Pleurectomy/Decortication vs. Extrapleural Pneumonectomy
Peritonectomy/Cytoreductive Surgery
Thoracotomy
Thoracoscopy
Pericardiectomy
Wedge Resection
Pleurodesis
Pericardiocentesis
Prosthetics
Paracentesis
Thoracentesis
Chemotherapy
Side Effects
Heated Intraperitoneal
Radiation Therapy
Side Effects
Intensity-Modulated
Brachytherapy
Proton Therapy
Image-Guided
External Beam
Three-Dimensional
Multimodal Therapy
New Treatments
SMART Protocol
Gene Therapy
Suicide Gene Therapy
Tumor-Based p53 Therapy
Cryotherapy for Mesothelioma
Tumor Treating Fields
MicroRNA
Palliative Treatment
Osteopathic
Doctors
Treatment Centers
Treatment & Doctors Near You
Mesothelioma Experts
Medications
Alimta (pemetrexed)
Adriamycin (doxorubicin)
Avastin (bevacizumab)
Cytoxan (cyclophosphamide)
Gemzar (gemcitabine)
Keytruda (Pembrolizumab)
Mitomycin
Navelbine (vinorelbine)
Opdivo (nivolumab) and Yervoy (ipilimumab)
Paraplatin (carboplatin)
Platinol (cisplatin)
Rheumatrex (methotrexate)
Sutent (sunitinib)
Taxol (paclitaxel)
Medical Marijuana
Care Providers
Clinical Trials
Anetumab Ravtansine
Atezolizumab
Chimeric Antigen Receptor (CAR) T-Cell
Durvalumab
Immunotoxin
Interferon Alfa-2b
Onconase (Ranpirnase)
VISTA Protein
Costs
Immunotherapy
Nanotechnology
Hyperbaric Oxygen Therapy
Home Medical Equipment
HMGB1 Secretion
Photodynamic Therapy
Targeted Therapies
Apoptosis
Stem Cells
Lung Transplantation
Body-Based Therapies
Alternative Therapies
Paul Kraus’s Method
Doctors and Treatment in Canada
Asbestos Trusts
Veterans
VA Claims for Mesothelioma
Vietnam Veterans
Military Branches and Asbestos
Navy Veterans
Navy Ships
Aircraft Carriers
Battleships
Destroyers
Asbestos on Navy Cruisers
Submarines
Amphibious Ships
Minesweepers
Auxiliary Ships
Marine Corps Veterans
Army Veterans
Air Force Veterans
U.S. Coast Guard
Asbestos
Occupational Exposure
Construction Workers
Shipyard Workers
Ship Repair
Steel Mill Workers
Industrial Workers
Boiler Workers
Power Plant Workers
Firefighters
Automotive Workers
Roofers
Oil Refineries
Mining
Transportation Industry
Machine Operators
Farmers and Agricultural Workers
Migrant Workers
Electrical Wiring
Labor Unions
Prisons
Chimneys, Furnaces, and Wood Stoves
Fiberglass Connection to Mesothelioma
Home Remodeling
School Buildings, Teachers
For Tech Students
Cancer
Lung Cancer
Pleural Based Cancers
Ovarian Cancer
Ovarian Cancer Lawsuits
Companies That Used Asbestos
Awareness and Education
Types of Asbestos & Mesothelioma Risk
Asbestosis
Interstitial Lung Disease
Smoking
Asbestos Ingestion
Exposure in a Natural Disaster
Ban Asbestos
Libby, Montana
Recycling Asbestos
Asbestos Detection
Legal Information by State
Canada
Mexico
United Kingdom
Australia
  • Malignant Mesothelioma
    • Treatment
    • Asbestos Trusts
  • Compensation
    • Veteran Assistance
    • Surviving Mesothelioma
  • FREE Mesothelioma Packet
    • Mesothelioma News
    • About Us / Contact
  • Privacy Policy
    • Disclaimer
    • Editorial Guidelines and Standards
This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.
The information provided by Mesothelioma.net is not a substitute for professional medical advice, diagnosis or treatment.

Mesothelioma.net

5430 LBJ Freeway Suite 1200
Dallas, Texas 75240

Serving mesothelioma victims nationwide

1-800-692-8608

  • facebook
  • twitter
© 2022 Mesothelioma.net